Healthcare >> CEO Interviews >> July 24, 2013
Harold R. Wolcott has served as a Director and President of BSD Medical Corporation since April 2009. Mr. Wolcott has 43 years experience managing and growing newly formed venture capital financed corporations as well as multi-million-dollar medical device businesses with international operations. He has a wide range of experience in the areas of product research, product engineering, manufacturing and plant management, as well as expertise in all aspects of sales and marketing, acquisition/integration and the sale of medical device businesses. Prior to joining the company, Mr. Wolcott served from August 2006 until March 2009 as President and Chief Operating Officer, and later as Director of Dimicron Inc., a development-stage medical company utilizing synthetic diamond for orthopedic applications. From March 2001 until June 2005, Mr. Wolcott served as Chief Operating Officer and Director of Rubicon Medical, Inc., a company focusing on proprietary technology in embolic protection for interventional cardiology and interventional neurology. Profile
TWST: What is BSD Medical?
Mr. Wolcott: BSD Medical was founded in 1978 and is listed on Nasdaq under BSDM. We have pioneered medical device systems for the treatment of cancer,